Pharmacy Prep by Dr. Misbah Biabani-15 years of Success in Pharmacy Exams Preparation
Consistently Delivering Success for Over 24 years Now Getting Even Better
You are visting USA Website    Visit Canadian Website    Visit AUS Website
Pharmacy Prep - Get Real Success
 DR. MISBAH REVIEWS
LOGIN
MCQ BANK
BLOG
TO SERVE YOU FASTER WHATSAPP/TEXT TO DR. MISBAH: 647-221-0457

THE LEADER IN PHARMACY EXAMS PREP COURSES

  • Pharmacy Prep - your gateway to success in Pharmacy Exams in Canada for last 15 years
  • PEBC Evaluating Exam
  • Pharmacist MCQ
  • Pharmacist OSCE
  • Technician MCQ
  • Technician OSPE
  • University Prep Courses
  • ASTRx - Drugs Resource
  • Pharmacy Software Training
  • Pebc Exam Books
  • Why Pharmacy Prep?
  • Instructors
  • Enroll Now
  • Testimonials
  • Contact Us
Menu

Chapter 30 Acute Coronary Syndrome Q&A (1 of 20) Sample Questions

1. MJ is a 49 year old woman who was recently admitted to the hospital after stating that she is experiencing severe chest pain, sweating, nausea and vomiting. Upon presentation to hospital emergency ECG and serum cardiac biomarker including creatine kinase- MB and troponin I tests were performed. Hospitalemergency provided the diagnosis of ST elevated myocardial infarction with blockade in right artery. Within 90 minutes of arrival of hospital emergency performed percutaneous infusion (PCI) and metal stent is placed to within right artery to restore blood flow to infarction area. Patients with acute coronary syndrome who had STEMI are at high risk of recurrent event as well as development of secondary complication. Antiplatelets therapy is critical for preventing recurrent thrombosis and particular important for patient who has received stent. Which of the following dual antiplatelet therapy should be continued for minimum 12 months?
  1. A. Acetyl Salicylic Acid (ASA)
  2. B. ASA/Dypridamole
  3. C. ASA/Clopidogrel
  4. D. ASA/Prasugrel
Answer
Ans: D
Tips: The use of Prasugrel should be considered in those patients with ACS undergoing stent implantation that is at higher risk for stent thrombosis (previous stent thrombosis, STEMI, history of diabetes mellitus).
PHARMACY PREP © 2025

Contact Details


Tel: 416–223–PREP(7737)
Mobile: 647–221–0457
WhatsApp:647-221-0457
(Click to chat)

Email: success@pharmacyprep.com

Address

MISSISSAUGA/BRAMPTON CAMPUS:
7900 Hurontario St. Unit 3
Brampton, ON, L6Y 0P6
Canada

TORONTO CAMPUS:
4750 Yonge Street, 3rd Floor, Unit 358
(Yonge St @ Sheppard Ave E)
Toronto, ON, M2N 0J6
Canada

pharmacyprep.com


Privacy Policy
Shipping/Return Policy
Disclaimer

Follow Us


Forums
www.tipscollege.com
www.physicianprep.com
www.eprepstation.com

Pharmacy Prep by Dr. Misbah Biabani-21 years of Success in Pharmacy Exams Preparation

WELCOME TO PHARMACY PREP

Please Chose Your Location

CANADA

USA

Save My Preference